Canada Strives for Commercial-free Drug Messaging
Province-wide pilot program to launch in spring
In what may be Canada’s largest experiment yet on academic detailing—the practice of healthcare professionals unaffiliated with drug companies updating doctors on available treatments—the Ontario Ministry of Health has issued a request for proposals to provide a province-wide pilot program. The proposal deadline is March 13, 2009, and the program may begin as early as May 1. It is expected to run for three years.
The health ministry has three objectives, according to spokesperson Andrew Morrison. The first is to provide physicians with objective, evidence-based comparative drug information. The second is to encourage use of the most therapeutically appropriate and cost-effective medications for each patient. Reducing drug expenditures in Ontario is the third objective.
The unstated objective behind the program, as well as other recent Canadian academic detailing initiatives, is to provide doctors current drug information that is free of commercial and off-label-use messages. “Academic detailing provides balanced messages in the face of perceived commercial influence of pharmaceutical company detailing,” according to a ministry document.
Canada has conducted similar academic-detailing initiatives in the past. In the U.S., the Independent Drug Information Service, brainchild of Harvard Med School faculty (and industry critic) Dr. Jerry Avorn, continues to perform academic detailing under a contract with the State of Pennsylvania.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
